|
|
Article: Cephalon and Eurand sue Mylan and Barr over generic Amrix.
- Article from:
- Pharma Marketletter
- Article date:
- December 1, 2008
CopyrightCOPYRIGHT 2008 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The USA's Cephalon and Dutch firm Eurand have commenced a law suit in the District Court of Delaware against generic drugmakers Mylan and Barr Laboratories regarding the latter two companies' Abbreviated New Drug Applications for two versions of the muscle relaxant Amrix (cyclobenzaprine HCl) extended-release capsules, used as adjunct in the treatment of acute musculoskeletal conditions. Cephalon and Eurand claim the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Caraco Pharmaceutical Files Two FDA Drug ...
PR Newswire;
September 7, 2000 ;
658 words
...Nine Drug Applications Filed, 21 Drugs Under Development ... Board: CARA) has filed two drug applications with the U.S. Food and Drug ... approvals for some of the Company's drug applications are anticipated next year. The ...
|
|